nilotinib
Generic: nilotinib
Labeler: torrent pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
nilotinib
Generic Name
nilotinib
Labeler
torrent pharmaceuticals limited
Dosage Form
CAPSULE
Routes
Active Ingredients
nilotinib hydrochloride monohydrate 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
13668-711
Product ID
13668-711_8e83f910-85f0-4646-b330-179f02acddf7
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA218532
Listing Expiration
2026-12-31
Marketing Start
2025-12-16
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
13668711
Hyphenated Format
13668-711
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nilotinib (source: ndc)
Generic Name
nilotinib (source: ndc)
Application Number
ANDA218532 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 4 BLISTER PACK in 1 CARTON (13668-711-57) / 28 CAPSULE in 1 BLISTER PACK
- 1 BLISTER PACK in 1 CARTON (13668-711-91) / 28 CAPSULE in 1 BLISTER PACK
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8e83f910-85f0-4646-b330-179f02acddf7", "openfda": {"unii": ["5JHU0N1R6K"], "rxcui": ["746606", "997653"], "spl_set_id": ["b34e7fd4-53c5-46d8-bf8a-1fcbe7a16504"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (13668-711-57) / 28 CAPSULE in 1 BLISTER PACK", "package_ndc": "13668-711-57", "marketing_start_date": "20251216"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (13668-711-91) / 28 CAPSULE in 1 BLISTER PACK", "package_ndc": "13668-711-91", "marketing_start_date": "20251216"}], "brand_name": "nilotinib", "product_id": "13668-711_8e83f910-85f0-4646-b330-179f02acddf7", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "13668-711", "generic_name": "nilotinib", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "nilotinib", "active_ingredients": [{"name": "NILOTINIB HYDROCHLORIDE MONOHYDRATE", "strength": "200 mg/1"}], "application_number": "ANDA218532", "marketing_category": "ANDA", "marketing_start_date": "20251216", "listing_expiration_date": "20261231"}